Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Bos JH"'
Publikováno v:
Clinical Epidemiology, Vol Volume 15, Pp 721-732 (2023)
Irene Mommers,1 Job FM van Boven,2,3 Catharina CM Schuiling-Veninga,1 Jens HJ Bos,1 Marten Koetsier,1 Eelko Hak,1 Maarten J Bijlsma1,4 1Pharmacotherapy, Epidemiology and -Economics, University of Groningen, Groningen, the Netherlands; 2Groningen Rese
Externí odkaz:
https://doaj.org/article/357d5d60fc4e4c9a93c1c60673eb1184
Publikováno v:
International Journal of General Medicine, Vol Volume 17, Pp 4947-4958 (2024)
Xuechun Li,1 Dennis Steenhuis,1 Maarten J Bijlsma,1,2 Stijn de Vos,1 Sumaira Mubarik,1 Jens HJ Bos,1 Catharina CM Schuiling-Veninga,1 Eelko Hak1 1Pharmacotherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Gro
Externí odkaz:
https://doaj.org/article/4ab4e93d498d471bb027ac497f0412b6
Autor:
Alfian, Sofa Dewi, Worawutputtapong, Pawida, Schuiling-Veninga, Catharina C.M., Van Der Schans, Jurjen, Bos, JH, Hak, Eelko, Denig, Petra
Publikováno v:
Pharmacoepidemiology and Drug Safety, 26(Supplement 2):856, 517-518. Wiley
Background: The use of statins as the most extensively used lipid-lowering therapy is known to be suboptimal in daily practice. Few studies, however, have looked at non-adherence and non-persistence as distinct phenomena. Objectives: To evaluate stat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::213cfdd81bfb74e9b68744ed4e2e4eca
https://research.rug.nl/en/publications/6ed757f4-de14-4f38-8f33-234407ee2e31
https://research.rug.nl/en/publications/6ed757f4-de14-4f38-8f33-234407ee2e31
Autor:
Sediq R, van der Schans J, Dotinga A, Alingh RA, Wilffert B, Bos JHJ, Schuiling-Veninga CCM, Hak E
Publikováno v:
Clinical Epidemiology, Vol Volume 10, Pp 981-989 (2018)
Rahmat Sediq,1 Jurjen van der Schans,1 Aafje Dotinga,2 Rolinde A Alingh,2 Bob Wilffert,1,3 Jens HJ Bos,1 Catharina CM Schuiling-Veninga,1 Eelko Hak1,4 1Department of Pharmaco-Therapy, Epidemiology & Economics, University of Groningen, Groningen Resea
Externí odkaz:
https://doaj.org/article/d8ca459f8b4a44c893ec2df39d5ff206
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elling T; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Hak E; Groningen Research Institute of Pharmacy, Unit of Pharmacotherapy, Epidemiology and Economy, University of Groningen, Groningen, The Netherlands., Bos JH; Groningen Research Institute of Pharmacy, Unit of Pharmacotherapy, Epidemiology and Economy, University of Groningen, Groningen, The Netherlands., Tichelaar VYIG; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Certe Thrombosis Service, Groningen, The Netherlands., Veeger NJGM; Department of Epidemiology, University of Groningen, University Medical Centre, Groningen, The Netherlands., Meijer K; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2024 Aug; Vol. 124 (8), pp. 778-790. Date of Electronic Publication: 2023 Sep 06.
Autor:
Wang Y; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institutte of Pharmacy, University of Groningen, Groningen, The Netherlands yuanyuanwang.research@gmail.com., Bos JH; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institutte of Pharmacy, University of Groningen, Groningen, The Netherlands., Schuiling-Veninga CCM; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institutte of Pharmacy, University of Groningen, Groningen, The Netherlands., Boezen HM; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van Boven JFM; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Wilffert B; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institutte of Pharmacy, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hak E; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institutte of Pharmacy, University of Groningen, Groningen, The Netherlands.; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Publikováno v:
BMJ open [BMJ Open] 2021 May 25; Vol. 11 (5), pp. e042417. Date of Electronic Publication: 2021 May 25.